Teva Pharmaceutical Indus (TEVA) Stock Price, Quote, News & History

Q: What sector and industry does Teva Pharmaceutical Indus (TEVA) operate in?

Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Comments

Teva Pharmaceutical Indus (TEVA) Stock Price, Quote, News & History

TEVANYSE

Logo brought to you by Benzinga Data

Trade with Public

$34.08

1.013.05%

At close: Jan 30, 4:00 PM EST

$34.10

0.02010.06%

After Hours: 7:59 PM EST

Q4 2025 Earnings were released on Wed Jan 28th, before the market open

The most recent conference call started at 8:00 AM, 3 days agoClick to view the webcast

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$32.49

Close

$34.08

Volume / Avg.

16.97M / 11.34M

Day Range

$32.35 - $34.11

52 Wk Range

12.47 - 33.44

Market Cap

$39.12B

P/E Ratio

27.33

Dividend Yield

-

Exchange

NYSE

RSI

74

Short Interest

2.88%

Days to Cover

4.72

Recent Teva Pharmaceutical Industries Ltd News

Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic

Lawsuit claims Novo Nordisk delayed generic Victoza using patent tactics and settlements, preserving monopoly pricing and shifting demand to Ozempic.

Vandana Singh

Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday?

Wall Street posted modest gains on Wednesday, while gold extended its relentless rally, shattering records above $5,300 an ounce ahead of the Federal Open Market Committee meeting.

Piero Cingari

Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook

Teva beat fourth-quarter estimates as drug sales surged, led by Austedo and Ajovy, while the company forecast steady earnings and revenue growth for 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.07B

Investing Cash Flow (TTM)

774.00M

Financing Cash Flow (TTM)

-2.87B

Free Cash Flow (TTM)

578.00M

Capital Expenditure (TTM)

-488.00M

Net Change in Cash (TTM)

-1.03B

Analyst Trends and Forecast

1

Sep 25

1

Oct 25

1

Nov 25

6

Dec 25

3

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$50.97B

PE Ratio (TTM)

27.33

PE Ratio (FWD)

11.64

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.23

PB Ratio (TTM)

4.80

Earnings Yield % (TTM)

3.66%

Earnings Yield % (FWD)

8.59%

EV / EBITDA (TTM)

16.79

Price / EBITDA (TTM)

12.61

Price / Free Cash Flow (TTM)

33.50

Book Value / Share

$6.89

Company Debt

Total Debt

$16.79B

LT Debt

$16.77B

LT Debt Issuance (TTM)

$2.30B

LT Debt Repayment (TTM)

-$4.80B

Total Cash

$2.20B

Debt to Equity

2.16

Issuance of Debt (TTM)

-$2.50B

Repayment of Debt (TTM)

-$4.80B

Key Statistics

Open

$32.49

Close

$34.08

Volume / Avg.

16.97M / 11.34M

Day Range

$32.35 - $34.11

52 Wk Range

12.47 - 33.44

Market Cap

$39.12B

P/E Ratio

27.33

Dividend Yield

-

Exchange

NYSE

RSI

74

Short Interest

2.88%

Days to Cover

4.72

About

Sector

Health Care

Industry

Pharmaceuticals

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Teva Pharmaceutical Indus (TEVA) stock?

A

You can purchase shares of Teva Pharmaceutical Indus (NYSE:TEVA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Teva Pharmaceutical Indus (TEVA) competitors?

A

Other companies in Teva Pharmaceutical Indus’s space includes: Novo Nordisk AS (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and Haleon PLC (NYSE:HLN).

Q

What is the forecast, or price target, for Teva Pharmaceutical Indus (TEVA) stock?

A

Teva Pharmaceutical Indus has a consensus price target of $29.54.

Q

What is the current price for Teva Pharmaceutical Indus (TEVA)?

A

The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $34.1001 last updated January 30, 2026 at 7:59 PM EST.

Q

Does Teva Pharmaceutical Indus (TEVA) pay a dividend?

A

There are no upcoming dividends for Teva Pharmaceutical Indus.

Q

When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?

A

Teva Pharmaceutical Indus does not have any upcoming earnings scheduled.

Q

Is Teva Pharmaceutical Indus (TEVA) going to split?

A

There is no upcoming split for Teva Pharmaceutical Indus.

Q

What sector and industry does Teva Pharmaceutical Indus (TEVA) operate in?

A

Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

People Also Watch

Axsome Therapeutics Inc

NASDAQ:AXSM

$181.22

-1.65%

Jazz Pharmaceuticals PLC

NASDAQ:JAZZ

$164.49

%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$32.49

Close

$34.08

Volume / Avg.

16.97M / 11.34M

Day Range

$32.35 - $34.11

52 Wk Range

12.47 - 33.44

Market Cap

$39.12B

P/E Ratio

27.33

Dividend Yield

-

Exchange

NYSE

RSI

74

Short Interest

2.88%

Days to Cover

4.72

Recent Teva Pharmaceutical Industries Ltd News

Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic

Lawsuit claims Novo Nordisk delayed generic Victoza using patent tactics and settlements, preserving monopoly pricing and shifting demand to Ozempic.

Vandana Singh

Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday?

Wall Street posted modest gains on Wednesday, while gold extended its relentless rally, shattering records above $5,300 an ounce ahead of the Federal Open Market Committee meeting.

Piero Cingari

Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook

Teva beat fourth-quarter estimates as drug sales surged, led by Austedo and Ajovy, while the company forecast steady earnings and revenue growth for 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.07B

Investing Cash Flow (TTM)

774.00M

Financing Cash Flow (TTM)

-2.87B

Free Cash Flow (TTM)

578.00M

Capital Expenditure (TTM)

-488.00M

Net Change in Cash (TTM)

-1.03B

Analyst Trends and Forecast

1

Sep 25

1

Oct 25

1

Nov 25

6

Dec 25

3

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$50.97B

PE Ratio (TTM)

27.33

PE Ratio (FWD)

11.64

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.23

PB Ratio (TTM)

4.80

Earnings Yield % (TTM)

3.66%

Earnings Yield % (FWD)

8.59%

EV / EBITDA (TTM)

16.79

Price / EBITDA (TTM)

12.61

Price / Free Cash Flow (TTM)

33.50

Book Value / Share

$6.89

Company Debt

Total Debt

$16.79B

LT Debt

$16.77B

LT Debt Issuance (TTM)

$2.30B

LT Debt Repayment (TTM)

-$4.80B

Total Cash

$2.20B

Debt to Equity

2.16

Issuance of Debt (TTM)

-$2.50B

Repayment of Debt (TTM)

-$4.80B

Key Statistics

Open

$32.49

Close

$34.08

Volume / Avg.

16.97M / 11.34M

Day Range

$32.35 - $34.11

52 Wk Range

12.47 - 33.44

Market Cap

$39.12B

P/E Ratio

27.33

Dividend Yield

-

Exchange

NYSE

RSI

74

Short Interest

2.88%

Days to Cover

4.72

About

Sector

Health Care

Industry

Pharmaceuticals

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry